Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 3, 2020
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study
Sandra Vukusic, Iuliana Ionescu, Catherine Cornu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Caroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.
Multiple Sclerosis and Related Disorders
|
November 17, 2017
Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?
Claire Rouzaud, Patrick Hautecoeur, Cécile Donze, et al.
Neurology
|
November 6, 2016
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy
Béatrice Pignolet, Nicholas Schwab, Tilman Schneider-Hohendorf, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 3, 2020
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study
Sandra Vukusic, Iuliana Ionescu, Catherine Cornu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Caroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.
Multiple Sclerosis and Related Disorders
|
November 17, 2017
Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?
Claire Rouzaud, Patrick Hautecoeur, Cécile Donze, et al.
Neurology
|
November 6, 2016
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy
Béatrice Pignolet, Nicholas Schwab, Tilman Schneider-Hohendorf, et al.
Page
of 5